Bayer AG Logo

Bayer AG

A global life science company with core competencies in healthcare and nutrition.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen

Description

Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 10:33 English 28.7 KB
2025-12-04 11:51 English 28.4 KB
2025-11-23 16:47
Bayer Aktiengesellschaft: Bayers Asundexian Met Primary Efficacy and Safety End…
English 8.8 KB
2025-11-17 00:00
Hinweis auf Konzernabschluss vom 01.01.2025 bis zum 31.12.2025
German 5.2 KB
2025-11-17 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2026 bis zum 30.06.2026
German 5.2 KB
2025-11-17 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2025 bis zum 31.12.2025
German 5.2 KB
2025-11-12 00:00
Q3 statement / Q3 financial report 2025
English 249.4 KB
2025-09-02 12:09 English 12.6 KB
2025-08-06 00:00
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55 English 86.6 KB
2025-07-31 23:15
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09 English 83.7 KB
2025-07-22 11:51 English 86.3 KB
2025-07-04 07:38 English 86.4 KB
2025-06-26 15:30 English 23.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.